Virtus LifeSci Biotech Clinical Trials ETF Rating $48.74 -1.53 (-3.04%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Virtus LifeSci Biotech Clinical Trials ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBC Aggregate RatingModerate Buy 2.73Holdings in BBC have an aggregate rating of Moderate Buy based on 341 analyst ratings issued in the past year covering 25 companies (24.2% of the portfolio).BBC Aggregate Price Target$48.74High Prediction$48.74Average Prediction$48.74Low Prediction$48.74Holdings in BBC have an aggregate price target of $48.74 and a range of $48.74 to $48.74 covering 25 companies (24.2% of the portfolio).BBC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Clinical Trials ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 BBC Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.33%TRAXFirst Tracks Biotherapeutics$44.04-7.8%1.7157 of 5 stars2.89$47.88 8.7%9News CoverageAnalyst Forecast1.21%ATAIAtai Beckley$7.182.7696 of 5 stars2.27$11.06 54.0%151.21%MNPRMonopar Therapeutics$108.35-5.5%1.7164 of 5 stars3.07$112.08 3.4%14Positive News1.15%MBXMBX Biosciences$65.93-0.8%1.8201 of 5 stars2.75$71.13 7.9%12News CoverageAnalyst Upgrade1.15%DFTXDefinium Therapeutics$43.52-2.2%3.3207 of 5 stars3.00$52.36 20.3%18News Coverage1.04%XNCRXencor$20.21-6.0%2.4896 of 5 stars2.50$24.25 20.0%10Upcoming EarningsAnalyst Forecast1.01%ZBIOZenas BioPharma$31.44-2.6%3.8877 of 5 stars2.56$44.29 40.9%9Positive News1.00%APGEApogee Therapeutics$134.09-0.2%1.9159 of 5 stars2.24$121.25 -9.6%21News CoveragePositive News0.96%ORICOric Pharmaceuticals$11.07-4.9%2.5619 of 5 stars2.75$19.27 74.1%16Positive News0.96%RGNXREGENXBIO$9.69-4.2%3.7883 of 5 stars2.62$23.82 145.8%13Upcoming Earnings0.95%SLSSELLAS Life Sciences Group$10.01-2.7%1.0745 of 5 stars2.33$10.00 -0.1%3Positive NewsOptions Volume0.93%QUREuniQure$43.63+3.4%3.5016 of 5 stars2.71$65.00 49.0%17News CoverageEarnings ReportAnalyst UpgradeGap Up0.91%NRIXNurix Therapeutics$23.21-1.6%2.598 of 5 stars2.80$34.00 46.5%15Analyst Forecast0.91%DMRADamora Therapeutics, Inc. Common Stock$28.99-0.8%2.0551 of 5 stars2.92$44.00 51.8%12News CoverageUpcoming EarningsAnalyst ForecastAnalyst Revision0.90%ERASErasca$18.15-2.8%2.1502 of 5 stars2.64$21.64 19.2%11Trending News0.88%DYNDyne Therapeutics$25.18-2.1%3.4562 of 5 stars2.87$34.42 36.7%15Earnings ReportAnalyst Forecast0.88%VORVor Biopharma$21.15-3.0%2.9051 of 5 stars2.82$42.25 99.8%110.87%ORKAOruka Therapeutics$96.51-1.4%3.5273 of 5 stars2.82$134.30 39.2%11News CoveragePositive News0.87%MPLTMaplight Therapeutics$13.02-7.2%3.1694 of 5 stars3.00$34.42 164.3%17News CoverageAnalyst ForecastInsider TradeGap UpHigh Trading Volume0.86%JBIOJade Biosciences$19.75-1.3%3.1714 of 5 stars2.90$51.57 161.1%10News CoveragePositive News0.85%GHRSGH Research$28.07-1.1%2.3941 of 5 stars2.67$40.78 45.3%12News CoverageUpcoming Earnings0.84%KYMRKymera Therapeutics$103.40-3.4%2.3672 of 5 stars2.83$124.48 20.4%23Positive NewsUpcoming EarningsAnalyst Forecast0.84%PVLAPalvella Therapeutics$139.04-7.4%3.4061 of 5 stars3.00$199.53 43.5%16News CoverageUpcoming EarningsAnalyst Upgrade0.84%SIONSionna Therapeutics$47.13+0.7%2.0003 of 5 stars2.85$53.22 12.9%13News Coverage0.84%BHVNBiohaven$13.49-2.4%3.3974 of 5 stars2.67$21.63 60.3%18 This page (NYSEARCA:BBC) was last updated on 7/31/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredBofA: Digital Dollar Coming 2025-2030Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | Sponsored“The unseen winner of the AI race” is not SpaceXMarc Chaikin - the analyst who called Nvidia before its historic run - says a tech firm labeled 'the unseen wi...Chaikin Analytics | SponsoredWhere to Put $100 Before Trump's New Tech Law Rolls OutThe Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBC Stock Alerts